Verified peer comparison
United States Antimony vs Kymera Therapeutics Financial Comparison
Direct answer
United States Antimony and Kymera Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free United States Antimony email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- United States Antimony Revenue
- 39,257,708 USD
- Kymera Therapeutics Revenue
- 39,200,000 USD
- United States Antimony Operating income
- -8,877,337 USD
- Kymera Therapeutics Operating income
- -349,400,000 USD